Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer

American Journal of Epidemiology

Volumn 156, Issue 8, 2002, Pages 693-701

  Goodman, Marc T ^a,f   Wu, Anna H ^b   Tung, Ko Hui ^a   McDuffie, Katharine ^a   Cramer, Daniel W ^c   Wilkens, Lynne R ^a   Terada, Keith ^d   Reichardt, Juergen K V ^b   Ng, Won G ^e  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF HAWAII   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Case control studies; Diet; Galactose; Lactose; Lactose intolerance; Milk; Ovarian neoplasms; Uridine diphosphate galactose

Indexed keywords

GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GONADOTROPIN; HEMOGLOBIN; ORAL CONTRACEPTIVE AGENT;

CANCER; DIET; HEALTH RISK; RISK FACTOR;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CARBOHYDRATE METABOLISM; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; OVARY CANCER; POPULATION RESEARCH; UNITED STATES;

ADULT; AGED; CALIFORNIA; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; GALACTOSE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAWAII; HUMANS; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; OVARY; RISK FACTORS; UTP-HEXOSE-1-PHOSPHATE URIDYLYLTRANSFERASE;

EID: 0037108312     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwf104     Document Type: Article

References (33)

1. Cramer DW. Lactase persistence and milk consumption as determinants of ovarian cancer risk. Am J Epidemiol 1989;130:904-10.
2. Dahlquist A. Lactose digestion and lactase deficiencies. In: Delmont J, ed. Milk intolerances and rejection. Basel, Switzerland: Karger, 1983:11-16.
3. Kaufman FR, Kogut MD, Donnell GN, et al. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981;304:994-8.
4. Cramer DW, Harlow BL, Willett WC, et al. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989;2:66-71.
5. Tyfield L, Reichardt J, Fridovich-Keil J, et al. Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat 1999;13:417-30.
6. Reichardt JKV, Woo SLC. Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridyltransferase. Proc Natl Acad Sci U S A 1991;88:2633-7.
7. Cramer DW, Greenberg ER, Titus-Emstoff L, et al. A case-control study of galactose consumption and metabolism in relation to ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000;9:95-101.
8. Goodman MT, Wu AH, Tung KH, et al. Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 2002;156:148-57.
9. Miller BA, Gloeckler Ries LAG, Hankey BF, et al, eds. Cancer statistics review 1973-89. Bethesda, MD: National Cancer Institute, 1992. (NIH publication no. 92-2789).
10. Oyama N, Johnson DB. Hawaii Health Surveillance Program survey methods and procedures. Honolulu, HI: Hawaii State Department of Health, Research and Statistics Office, 1986. (Research and statistics report no. 54).
11. Pike MC, Peters RK, Cozen W, et al. Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst 1997;89:1110-16.
12. Kolonel LN, Henderson BE, Hankin JH, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000;151:346-57.
13. US Department of Agriculture. USDA Nutrient Data Base for Standard Reference, release 10. Riverdale, MD: Nutrient Data Laboratory, Agricultural Research Service, 1993.
14. US Department of Agriculture. USDA Nutrient Data Base for Nationwide Food Surveys, release 7. Riverdale, MD: Nutrient Data Laboratory, Agricultural Research Service, 1991.
15. Pennington JAT. Bowes and Church food values of portions commonly used. 16th ed. Philadelphia, PA: J B Lippincott Co, 1994.
16. Holland B, Welch AA, Unwin ID, et al. McCance and Widdowson's the composition of foods. 5th ed. Cambridge, United Kingdom: Royal Society of Chemistry and Ministry of Agriculture, Fisheries and Food, 1991.
17. Kagawa R. Standard tables of food composition in Japan. Tokyo, Japan: Women's University, 1995.
18. Lee JES, Ng WG. Semi-micro techniques for the genotyping of galactokinase and galactose-1-phosphate uridyltransferase. Clin Chim Acta 1982;124:351-6.
19. Breslow NE, Day NE, eds. Statistical methods in cancer research. Vol I. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980. (IARC scientific publication no. 32).
20. Mehta CR, Patel NR, Gray R. Computing an exact confidence interval for the common odds ratio in several 2 × 2 contingency tables. J Am Stat Assoc 1986;80:969-73.
21. Snedecor GW, Cochran WG. Statistical methods. Ames, IA: Iowa State University Press, 1967.
22. Webb PM, Bain CJ, Purdie DM, et al. Milk consumption, galactose metabolism and ovarian cancer (Australia). Cancer Causes Control 1998;9:637-44.
23. Kushi LH, Mink PJ, Folsom AR, et al. Prospective study of diet and ovarian cancer. Am J Epidemiol 1999;149:21-31.
24. Cramer DW, Welch WR, Hutchison GB, et al. Dietary animal fat in relation to ovarian cancer risk. Obstet Gynecol 1984;63:833-8.
25. Herrinton LJ, Weiss NS, Beresford SAA, et al. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer. Am J Epidemiol 1995;141:407-16.
26. Harlow BL, Cramer DW, Geller J, et al. The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk. Am J Epidemiol 1991;134:445-53.
27. Morland SJ, Jiang S, Hitchcock A, et al. Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis. Int J Cancer 1998;77:825-7.
28. Elsas LJ 2nd, Lai K. The molecular biology of galactosemia. Genet Med 1998;1:40-8.
29. Lin CH, Kirby LT, Ng WG, et al. On the molecular nature of the Duarte variant of galactose-1-phosphate uridyltransferase (GALT). Hum Genet 1994;93:167-9.
30. Elsas LJ, Lai K, Saunders CJ, et al. Functional analysis of the human galactose-1-phosphate uridyltransferase promoter in Duarte and LA variant galactosemia. Mol Genet Metab 2001;72:297-305.
31. Trbusek M, Francova H, Kozak L. Galactosemia: deletion in the 5′ upstream region of the GALT gene reduces promoter efficiency. Hum Genet 2001;109:117-20.
32. Hankin JH, Wilkens LR, Kolonel LN, et al. Validation of a quantitative diet history method in Hawaii. Am J Epidemiol 1991;133:616-28.
33. Hankin JH, Nomura AM, Lee J, et al. Reproducibility of a diet history questionnaire in a case-control study of breast cancer. Am J Clin Nutr 1983;37:981-5.